20 - Characterization of Novel Oral Splicing Modulator, H3B-8800, Identifies the Mechanistic Basis for its Preferential Lethality Towards Spliceosome-Mutant Myeloid Malignancy Models
| Autor: | Buonamici, S., Yoshimi, A., Thomas, M., Seiler, M., Chan, B., Csibi, A., Fekkes, P., Klimek, V., Kumar, P., Lee, S.C.W., Padron, E., Pazolli, E., Goldberg, J., Sahmoud, T., Taylor, J., Warmuth, M., Yu, L., Zhu, P., Abdel-Wahab, O., Smith, P. |
|---|---|
| Zdroj: | In Leukemia Research April 2017 55 Supplement 1:S11-S11 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect